IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 70 filers reported holding IVERIC BIO INC in Q4 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,322,702 | +214.7% | 135,300 | +71.3% | 0.01% | +180.0% |
Q4 2022 | $1,691,390 | -84.3% | 79,000 | -86.9% | 0.01% | -83.9% |
Q3 2022 | $10,782,000 | -31.2% | 601,000 | -63.1% | 0.03% | -29.5% |
Q2 2022 | $15,670,000 | -27.0% | 1,628,900 | +27.7% | 0.04% | -22.8% |
Q1 2022 | $21,462,000 | -1.0% | 1,275,200 | -1.6% | 0.06% | +5.6% |
Q4 2021 | $21,672,000 | +55.8% | 1,296,200 | +51.3% | 0.05% | +50.0% |
Q3 2021 | $13,913,000 | +513.2% | 856,700 | +138.2% | 0.04% | +500.0% |
Q2 2021 | $2,269,000 | +50.5% | 359,600 | +47.4% | 0.01% | +50.0% |
Q1 2021 | $1,508,000 | +15.3% | 244,000 | +28.9% | 0.00% | +33.3% |
Q4 2020 | $1,308,000 | +93.5% | 189,300 | +58.0% | 0.00% | +50.0% |
Q3 2020 | $676,000 | -0.3% | 119,800 | -9.9% | 0.00% | 0.0% |
Q2 2020 | $678,000 | +162.8% | 133,000 | +77.3% | 0.00% | +100.0% |
Q1 2020 | $258,000 | +9.8% | 75,000 | +173.7% | 0.00% | 0.0% |
Q4 2019 | $235,000 | +351.9% | 27,400 | -40.6% | 0.00% | – |
Q3 2019 | $52,000 | -29.7% | 46,100 | -18.7% | 0.00% | – |
Q2 2019 | $74,000 | – | 56,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |